» Articles » PMID: 20463014

Molecular Consequences of the ACVR1(R206H) Mutation of Fibrodysplasia Ossificans Progressiva

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2010 May 14
PMID 20463014
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrodysplasia ossificans progressiva (FOP), a rare genetic and catastrophic disorder characterized by progressive heterotopic ossification, is caused by a point mutation, c.617G>A; p.R206H, in the activin A receptor type 1 (ACVR1) gene, one of the bone morphogenetic protein type I receptors (BMPR-Is). Although altered BMP signaling has been suggested to explain the pathogenesis, the molecular consequences of this mutation are still elusive. Here we studied the impact of ACVR1 R206H mutation on BMP signaling and its downstream signaling cascades in murine myogenic C2C12 cells and HEK 293 cells. We found that ACVR1 was the most abundant of the BMPR-Is expressed in mesenchymal cells but its contribution to osteogenic BMP signal transduction was minor. The R206H mutant caused weak activation of the BMP signaling pathway, unlike the Q207D mutant, a strong and constitutively active form. The R206H mutant showed a decreased binding affinity for FKBP1A/FKBP12, a known safeguard molecule against the leakage of transforming growth factor (TGF)-beta or BMP signaling. The decreased binding affinity of FKBP1A to the mutant R206H ACVR1 resulted in leaky activation of the BMP signal, and moreover, it decreased steady-state R206H ACVR1 protein levels. Interestingly, while WT ACVR1 and FKBP1A were broadly distributed in plasma membrane and cytoplasm without BMP-2 stimulation and then localized in plasma membrane on BMP-2 stimulation, R206H ACVR1 and FKBP1A were mainly distributed in plasma membrane regardless of BMP-2 stimulation. The impaired binding to FKBP1A and an altered subcellular distribution by R206H ACVR1 mutation may result in mild activation of osteogenic BMP-signaling in extraskeletal sites such as muscle, which eventually lead to delayed and progressive ectopic bone formation in FOP patients.

Citing Articles

Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance.

Liu F, Zhao Y, Pei Y, Lian F, Lin H Cell Commun Signal. 2024; 22(1):159.

PMID: 38439078 PMC: 10910758. DOI: 10.1186/s12964-024-01533-w.


Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.

Anwar S, Yokota T Genes (Basel). 2023; 14(12).

PMID: 38136984 PMC: 10742611. DOI: 10.3390/genes14122162.


FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy.

Mina E, Wyart E, Sartori R, Angelino E, Zaggia I, Rausch V Cell Rep Med. 2023; 4(12):101306.

PMID: 38052214 PMC: 10772350. DOI: 10.1016/j.xcrm.2023.101306.


Polypeptide Substrate Accessibility Hypothesis: Gain-of-Function R206H Mutation Allosterically Affects Activin Receptor-like Protein Kinase Activity.

Groppe J, Lu G, Tandang-Silvas M, Pathi A, Konda S, Wu J Biomolecules. 2023; 13(7).

PMID: 37509165 PMC: 10376983. DOI: 10.3390/biom13071129.


Functional comparison of human ACVR1 and zebrafish Acvr1l FOP-associated variants in embryonic zebrafish.

Lalonde R, Nicolas H, Cutler R, Pantekidis I, Zhang W, Yelick P Dev Dyn. 2023; 252(5):605-628.

PMID: 36606464 PMC: 10311797. DOI: 10.1002/dvdy.566.


References
1.
Liu F, Ventura F, Doody J, Massague J . Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol. 1995; 15(7):3479-86. PMC: 230584. DOI: 10.1128/MCB.15.7.3479. View

2.
Lee K, Kim H, Li Q, Chi X, Ueta C, Komori T . Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol. 2000; 20(23):8783-92. PMC: 86511. DOI: 10.1128/MCB.20.23.8783-8792.2000. View

3.
Olmsted-Davis E, Gannon F, Ozen M, Ittmann M, Gugala Z, Hipp J . Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol. 2007; 170(2):620-32. PMC: 1851874. DOI: 10.2353/ajpath.2007.060692. View

4.
Fukuda T, Kohda M, Kanomata K, Nojima J, Nakamura A, Kamizono J . Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem. 2008; 284(11):7149-56. PMC: 2652274. DOI: 10.1074/jbc.M801681200. View

5.
Esapa C, McIlhinney R, Blake D . Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells. Hum Mol Genet. 2004; 14(2):295-305. DOI: 10.1093/hmg/ddi026. View